Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
1726
DELISTED
Radius Recycling
RDUS
| $25.3M | ﹤0.01% |
486,851
+25,755
| +6% | +$1.16M |
|
1727
Amphastar Pharmaceuticals
AMPH
$879M
| $25.3M | ﹤0.01% |
703,479
-11,394
| -2% | -$323K |
|
1728
TriMas Corp
TRS
$1.43B
| $25.2M | ﹤0.01% |
786,226
+22,309
| +3% | +$744K |
|
1729
Green Dot
GDOT
$745M
| $25.2M | ﹤0.01% |
916,827
-44,664
| -5% | -$1.36M |
|
1730
Arcus Biosciences
RCUS
$3.52B
| $25.2M | ﹤0.01% |
797,542
+28,030
| +4% | +$939K |
|
1731
Agilon Health
AGL
$1.62B
| $25.2M | ﹤0.01% |
39,708
+2,262
| +6% | +$1.17M |
|
1732
Cerence
CRNC
$408M
| $25.2M | ﹤0.01% |
697,098
+35,416
| +5% | +$1.74M |
|
|
OPI
1733
DELISTED
Office Properties Income Trust
OPI
| $25.1M | ﹤0.01% |
977,060
+26,802
| +3% | +$681K |
|
|
ADAM
1734
Adamas Trust
ADAM
$839M
| $25.1M | ﹤0.01% |
1,721,771
+71,229
| +4% | +$1.04M |
|
1735
8x8 Inc
EGHT
$286M
| $25.1M | ﹤0.01% |
1,996,272
+147,877
| +8% | +$2.05M |
|
1736
Enanta Pharmaceuticals
ENTA
$373M
| $25.1M | ﹤0.01% |
352,716
+16,708
| +5% | +$1.09M |
|
|
HEES
1737
DELISTED
H&E Equipment Services
HEES
| $25.1M | ﹤0.01% |
576,706
+15,474
| +3% | +$651K |
|
|
LADR
1738
Ladder Capital
LADR
$1.23B
| $25.1M | ﹤0.01% |
2,114,183
+143,805
| +7% | +$1.69M |
|
1739
Gibraltar Industries
ROCK
$1.33B
| $25.1M | ﹤0.01% |
584,113
+7,768
| +1% | +$409K |
|
1740
Community Health Systems
CYH
$409M
| $25.1M | ﹤0.01% |
2,113,153
+65,429
| +3% | +$796K |
|
|
CCXI
1741
DELISTED
ChemoCentryx, Inc.
CCXI
| $25.1M | ﹤0.01% |
1,000,415
+68,246
| +7% | +$1.92M |
|
|
PRA
1742
DELISTED
ProAssurance
PRA
| $25.1M | ﹤0.01% |
932,834
+19,339
| +2% | +$478K |
|
1743
First Commonwealth Financial
FCF
$2.19B
| $25.1M | ﹤0.01% |
1,652,404
+35,300
| +2% | +$573K |
|
1744
Veeco
VECO
$3.08B
| $25M | ﹤0.01% |
919,170
+3,965
| +0.4% | +$112K |
|
1745
Oxford Industries
OXM
$581M
| $25M | ﹤0.01% |
275,812
+4,524
| +2% | +$399K |
|
1746
Protolabs
PRLB
$1.88B
| $25M | ﹤0.01% |
471,799
-44,172
| -9% | -$2.32M |
|
1747
NeoGenomics
NEO
$2.06B
| $24.9M | ﹤0.01% |
2,051,162
-450
| -0% | -$9.47K |
|
1748
Universal Corp
UVV
$1.31B
| $24.9M | ﹤0.01% |
428,640
+14,755
| +4% | +$812K |
|
1749
Transocean
RIG
$5.79B
| $24.9M | ﹤0.01% |
5,440,937
+184,978
| +4% | +$704K |
|
1750
Unisys
UIS
$225M
| $24.7M | ﹤0.01% |
1,144,726
+48,973
| +4% | +$991K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.